Welcome back to the Barbell Medicine Podcast where we bring Modern Medicine

Medicine and Strength and Conditioning in Modern Medicine. I'm your host

Dr. Jordan Feigenbaum. This is episode 281. Great debates in fitness and in health.

This is our fourth iteration of that, but it's part two. It ran a little long the last time we were recording.

We're up to an hour and 45 minutes of audio and honestly

no one's going to sit through that at least I don't think so so we split it up on this particular

episode we're arguing over whether or not GLP1 receptor agonists like we go,

Viozemphic and so on cause additional muscle loss

compared to other methods of weight management.

What's up with BMI?

Why do people keep talking about it if it's so terrible?

Cross-fit is cross-fit good or bad for health and performance.

Exercise and pregnancy, specifically are the current recommendations good enough

to promote health in pregnant women and finally over training does

over training exist in resistance training again this is episode 281 great

debates in fitness and health with myself dr jordan feigenbaum and Dr Austin Baraki.

Let's get right into it.

Next question. This is on GLP1 receptor agonists, so things like some aglutide,

Ozemphic, we go v, etc. and muscle loss.

When there is an overall energy deficit that is less calories have been consumed than are being used

over a sustained period of time, people lose weight. Stored fat is

liberated from body fat and used as energy as well as other energy stores in the body,

...